Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica
Tài liệu tham khảo
Sobradillo, 2000, Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC Multicentre Epidemiological Study, Chest, 118, 981, 10.1378/chest.118.4.981
MacFarlane, 1993, Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community, Lancet, 341, 511, 10.1016/0140-6736(93)90275-L
Woodhead, 1996, Use of investigations in lower respiratory tract infection in the community: a European survey, Eur Respir J, 9, 1596, 10.1183/09031936.96.09081596
Huchon, 1996, Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey, Eur Respir J, 9, 1590, 10.1183/09031936.96.09081590
Romero Vivas, 1997, Estudio de las infecciones respiratorias extrahospitalarias, Enferm Infecc Microbiol Clin, 15, 289
Eller, 1998, Infective exacerbations of chronic bronchitis. Relation between bacteriologic etiology and lung function, Chest, 113, 1542, 10.1378/chest.113.6.1542
Monsó, 1995, Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated out-patients using the protected specimen brush, Am J Respir Crit Care Med, 152, 1316, 10.1164/ajrccm.152.4.7551388
Soler, 1998, Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation, Am J Respir Crit Care Med, 157, 1498, 10.1164/ajrccm.157.5.9711044
Xu, 1993, Association of indoor and outdoor particulate pollution level with chronic respiratory illness, Am Rev Respir Dis, 148, 1516, 10.1164/ajrccm/148.6_Pt_1.1516
Tashkin, 1994, The UCLA population studies of chronic obstructive pulmonary disease. XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second, Am J Respir Crit Care Med, 149, 1067, 10.1164/ajrccm.149.5.8173761
1991, Lung function testing: selection of reference values and interpretative strategies, Am Rev Respir Dis, 144, 1202, 10.1164/ajrccm/144.5.1202
Postma, 1998, When can an exacerbation of COPD be treated at home?, Lancet, 351, 1827, 10.1016/S0140-6736(05)78798-5
Chaouat, 1999, A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients, Eur Respir J, 14, 1002, 10.1183/09031936.99.14510029
Connors, 1996, Outcomes following acute exacerbations of severe chronic obstructive lung disease, Am J Respir Crit Care Med, 154, 959, 10.1164/ajrccm.154.4.8887592
Murata, 1989, Use of emergency medical services by patients with decompensated obstructive lung disease, Ann Emerg Med, 18, 501, 10.1016/S0196-0644(89)80833-9
Emerman, 1991, Spirometric criteria for hospital admission of patients with acute exacerbation of COPD, Chest, 99, 595, 10.1378/chest.99.3.595
Kessler, 1999, Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 159, 158, 10.1164/ajrccm.159.1.9803117
Mahler, 1987, Comparison of clinical dysnea ratings and psychophysical measurementes of respiratory sensation in obstructive airways disease, Am Rev Respir Dis, 165, 1229, 10.1164/arrd.1987.135.6.1229
Fagon, 1990, Characterization of distal bronchial microflora during acute exacerbations of chronic bronchitis: use of the protected specimen brush technique in 54 mechanically ventilated patients, Am Rev Respir Dis, 142, 1004, 10.1164/ajrccm/142.5.1004
Cabello, 1997, Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study, Eur Respir J, 10, 1137, 10.1183/09031936.97.10051137
Heffelfinger, 2000, Management of community acquired pneumonia in the era of pneumococcal resistance: a report from drug-resistant Streptococcus pneumoniae. Therapeutic Working Group, Arch Int Med, 160, 1339, 10.1001/archinte.160.10.1399
Ewig, 1999, Evaluation of antimicrobial treatment in patients with severe exacerbations of chronic pulmonary disease, Clin Pulm Med, 6, 1, 10.1097/00045413-199901000-00001
Rosón, 2000, Prospective study of the usefulness of Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization, Clin Infect Dis, 31, 869, 10.1086/318151
Chodosh, 1992, Bronchitis and asthma, 476
Lindsay, 1992, Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: A randomized, double-blind trial, J Antimicrob Chemother, 13, 89, 10.1093/jac/30.1.89
Anzueto, 1998, Etiology, susceptibility and treatment of acute bacterial exacerbations for complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d, Clin Ther, 20, 885, 10.1016/S0149-2918(98)80071-4
Baquero, 1999, The Spanish Surveillance group: antimicrobial resistance of 1113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1 year (1996–1997) multicenter surveillance study, Antimicrob Agents Chemother, 43, 357, 10.1128/AAC.43.2.357
Bouza, 1999, Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group, Anti-microb Agents Chemother, 43, 981, 10.1128/AAC.43.4.981
Pollock, 1983, Diagnosis of bacterial pulmonary infections with quantitative protected catheter cultures obtained during bronchoscopy, J Clin Microbiol, 17, 255, 10.1128/JCM.17.2.255-259.1983
Fagon, 1990, Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients, Am Rev Respir Dis, 142, 1004, 10.1164/ajrccm/142.5.1004
Murphy, 2000, Haemophilus influenzae in chronic bronchitis, Semin Respir Infect, 15, 41, 10.1053/srin.2000.0150041
Murphy, 1992, Bacterial infection in chronic obstructive pulmonary disease, Am Rev Respir Dis, 146, 1067, 10.1164/ajrccm/146.4.1067
Lehmann, 1991, Reduction in the incidence of acute bronchitis by an oral Haemophilus influenzae vaccine in patients with chronic bronchitis in the highlands of Papua New Guinea, Am Rev Respir Dis, 144, 324, 10.1164/ajrccm/144.2.324
Tandon, 1991, A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis, Aust N Z J Med, 21, 427, 10.1111/j.1445-5994.1991.tb01346.x
Clancy, 1985, Oral immunization with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease, Lancet, II, 1395, 10.1016/S0140-6736(85)92559-0
Clancy, 1990, Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae, Med J Aust, 152, 413, 10.5694/j.1326-5377.1990.tb125268.x
Foxwell, 2000, Haemophilus influenzae oral vaccination against acute bronchitis, Cochrane Database Syst Rev
Nelson, 1988, Studies on P6, an important outer-membrane protein antigen of Haemophilus influenzae, Rev Infect Dis, 10, S331, 10.1093/cid/10.Supplement_2.S331
Kyd, 1995, Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model, Infect Immun, 63, 2931, 10.1128/IAI.63.8.2931-2940.1995
1999, WHO position paper, Wkly Epidemiol Rec, 74, 177
Bacle, 1997, Vaccin anti-pneumococcique: Justifications et resultats, Rev Pneumol Clin, 53, 128
Buscho, 1978, Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis, J Infect Dis, 137, 377, 10.1093/infdis/137.4.377
Soler, 1998, Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation, Am J Respir Crit Care Med, 157, 1498, 10.1164/ajrccm.157.5.9711044
Poole, 2001, 1
Ahmed, 1997, Effectiveness of influenza vaccine in reducing hospital admissions during the 1989–90 epidemic, Epidemiol Infect, 118, 27, 10.1017/S0950268896007121